These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 31257722)
21. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy. Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D Recent Pat Nanotechnol; 2024; 18(4):395-414. PubMed ID: 37537775 [TBL] [Abstract][Full Text] [Related]
22. Challenges of clinical translation in nanomedicine: A qualitative study. Satalkar P; Elger BS; Hunziker P; Shaw D Nanomedicine; 2016 May; 12(4):893-900. PubMed ID: 26772431 [TBL] [Abstract][Full Text] [Related]
23. Nanoncology. Ferrari M Tumori; 2008; 94(2):197-9. PubMed ID: 18564607 [No Abstract] [Full Text] [Related]
24. Nanotechnology platforms and physiological challenges for cancer therapeutics. Kim KY Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621 [TBL] [Abstract][Full Text] [Related]
25. Nanotechnology: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489 [TBL] [Abstract][Full Text] [Related]
26. Measuring hot flashes: summary of a National Institutes of Health workshop. Miller HG; Li RM Mayo Clin Proc; 2004 Jun; 79(6):777-81. PubMed ID: 15182093 [TBL] [Abstract][Full Text] [Related]
27. Delivering the power of nanomedicine to patients today. Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950 [TBL] [Abstract][Full Text] [Related]
28. Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Minasian LM; Carpenter WR; Weiner BJ; Anderson DE; McCaskill-Stevens W; Nelson S; Whitman C; Kelaghan J; O'Mara AM; Kaluzny AD Cancer; 2010 Oct; 116(19):4440-9. PubMed ID: 20572032 [TBL] [Abstract][Full Text] [Related]
29. Image-guided tumor surgery: The emerging role of nanotechnology. Wojtynek NE; Mohs AM Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1624. PubMed ID: 32162485 [TBL] [Abstract][Full Text] [Related]
30. Biotargeted nanomedicines for cancer: six tenets before you begin. Goldberg MS; Hook SS; Wang AZ; Bulte JW; Patri AK; Uckun FM; Cryns VL; Hanes J; Akin D; Hall JB; Gharkholo N; Mumper RJ Nanomedicine (Lond); 2013 Feb; 8(2):299-308. PubMed ID: 23394158 [TBL] [Abstract][Full Text] [Related]
31. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. Wang W; Jin Y; Xu Z; Liu X; Bajwa SZ; Khan WS; Yu H Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1614. PubMed ID: 32011108 [TBL] [Abstract][Full Text] [Related]
32. Nanomedicine applied to translational oncology: A future perspective on cancer treatment. Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707 [TBL] [Abstract][Full Text] [Related]
33. Advances in Translational Nanotechnology: Challenges and Opportunities. Mohapatra SS; Frisina RD; Mohapatra S; Sneed KB; Markoutsa E; Wang T; Dutta R; Damnjanovic R; Phan MH; Denmark DJ; Biswal MR; McGill AR; Green R; Howell M; Ghosh P; Gonzalez A; Ahmed NT; Borresen B; Farmer M; Gaeta M; Sharma K; Bouchard C; Gamboni D; Martin J; Tolve B; Singh M; Judy JW; Li C; Santra S; Daunert S; Zeynaloo E; Gelfand RM; Lenhert S; McLamore ES; Xiang D; Morgan V; Friedersdorf LE; Lal R; Webster TJ; Hoogerheide DP; Nguyen TD; D'Souza MJ; Çulha M; Kondiah PPD; Martin DK Appl Sci (Basel); 2020; 10(14):. PubMed ID: 38486792 [TBL] [Abstract][Full Text] [Related]
34. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory. Caputo F; Mehn D; Clogston JD; Rösslein M; Prina-Mello A; Borgos SE; Gioria S; Calzolai L J Chromatogr A; 2021 Jan; 1635():461767. PubMed ID: 33310281 [TBL] [Abstract][Full Text] [Related]
35. Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. Crist RM; Grossman JH; Patri AK; Stern ST; Dobrovolskaia MA; Adiseshaiah PP; Clogston JD; McNeil SE Integr Biol (Camb); 2013 Jan; 5(1):66-73. PubMed ID: 22772974 [TBL] [Abstract][Full Text] [Related]
36. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609 [TBL] [Abstract][Full Text] [Related]
37. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Milane L; Amiji M Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669 [TBL] [Abstract][Full Text] [Related]
38. Mapping the Nanotechnology Patent Landscape in the Field of Cancer. Sun H; Wu T; Liu X; Xia H; Yuan H Recent Pat Nanotechnol; 2024; 18(3):321-334. PubMed ID: 37259209 [TBL] [Abstract][Full Text] [Related]
39. Strategic workshops on cancer nanotechnology. Nagahara LA; Lee JS; Molnar LK; Panaro NJ; Farrell D; Ptak K; Alper J; Grodzinski P Cancer Res; 2010 Jun; 70(11):4265-8. PubMed ID: 20460532 [TBL] [Abstract][Full Text] [Related]
40. Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions. Ahmad F; Muhmood T Colloids Surf B Biointerfaces; 2024 Sep; 241():114041. PubMed ID: 38897022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]